---

Pulmonary embolism: A brief review

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Harshita Arun Pardhe*, Hariprasad MG, Nagalakshmi NC, Prabhat Kumar Chourasia, Pallavi N

Volume : 5, Issue : 1, Year : 2020

Article Page : 6-8

https://doi.org/10.18231/j.ijcaap.2020.002

Suggest article by email

Get Permission

Abstract

Pulmonary embolism (PE) is characterized as pulmonary artery obstruction caused by a thrombotic embolus the usual clinical presence of acute PE involves a patient with a sudden onset of dyspnea and pleuritic chest pain at breathing, while blood coughing (hemoptysis), signs of deep vein thrombosis (DVT) and even collapse are less prevalent. PE is classified as PE which is massive, sub-massive and low risk. PE is a significant cause of morbidity and mortality among the patients who are hospitalized. When venous clot is dislodged from the place where it was actually formed, the clot then proceeds towards a vessel of pulmonary circulation leading to pulmonary embolism. Many factors affect pulmonary embolism such as prolonged immobility, advanced age, postoperative time, post-infarction period, heart failure, obesity, pregnancy, etc. Treatment mainly involves anti- coagulants. This brief review summarizes the pathophysiology, risk factors and treatment, management and supportive measures involved in Pulmonary embolism.

Keywords: Pulmonary Embolism, Deep vein thrombosis, Bronchospasm, Thromboembolism.

How to cite : Pardhe H A, Hariprasad Mg, Nagalakshmi Nc, Chourasia P K, Pallavi N, Pulmonary embolism: A brief review. IP Int J Compr Adv Pharmacol 2020;5(1):6-8

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.